Congo, Democratic Republic of the vs Rwanda: Average cost of multi drug-resistant tuberculosis treatment
Congo, Democratic Republic of the
896 constant 2022 US$
in 2024
Rwanda
876 constant 2022 US$
in 2024
Congo, Democratic Republic of the rank
54th
Rwanda rank
56th
Average cost of multi drug-resistant tuberculosis treatment over time
- Congo, Democratic Republic of the
- Rwanda
How they compare
Congo, Democratic Republic of the currently reports 896 constant 2022 US$ against 876 constant 2022 US$ in Rwanda, a difference of 20 constant 2022 US$.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 54th and Rwanda ranks 56th of 92 countries.
Across the 2 decades both report, Congo, Democratic Republic of the averaged higher in 1 and Rwanda in 1.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,332 constant 2022 US$ | 1,084 constant 2022 US$ | 247.67 constant 2022 US$ | Congo, Democratic Republic of the |
| 2020s | 940 constant 2022 US$ | 958.6 constant 2022 US$ | 18.6 constant 2022 US$ | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Congo, Democratic Republic of the or Rwanda?
- Congo, Democratic Republic of the, at 896 constant 2022 US$ against 876 constant 2022 US$ in Rwanda as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Congo, Democratic Republic of the and Rwanda?
- 20 constant 2022 US$, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Rwanda?
- 8 years are reported by both, from 2017 to 2024.
- How do Congo, Democratic Republic of the and Rwanda rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Congo, Democratic Republic of the ranks 54th and Rwanda ranks 56th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.